Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Cash and Equivalents of $58.45 million for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $58.45M | +52.4% |
| 2024 | $38.34M | +93.3% |
| 2023 | $19.84M | -62.1% |
| 2022 | $52.42M | +14.9% |
| 2021 | $45.63M | -23.2% |
| 2020 | $59.44M | +27.2% |
| 2019 | $46.73M | +12.7% |
| 2018 | $41.47M | -49.4% |
| 2017 | $82.03M | +187.1% |
| 2016 | $28.57M | +5.4% |
| 2015 | $27.11M | -6.8% |
| 2014 | $29.09M | +7.5% |
| 2013 | $27.06M | +32.1% |
| 2012 | $20.49M | -44.6% |
| 2011 | $36.98M | +153.8% |
| 2010 | $14.57M | +17825.2% |
| 2009 | $81.3K | +412.8% |
| 2008 | $15.9K | — |
| 2005 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.53M | -20.8% | -6.1% |
| June 30, 2025 | $24.01M | +25.0% | +2.5% |
| March 31, 2025 | $23.41M | +24.9% | -38.9% |
| December 31, 2024 | $38.34M | +93.3% | +34.8% |
| September 30, 2024 | $28.45M | +6.7% | +48.1% |
| June 30, 2024 | $19.21M | -11.2% | +2.4% |
| March 31, 2024 | $18.75M | -56.9% | -5.5% |
| December 31, 2023 | $19.84M | -62.1% | -25.6% |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +52.4% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: